Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Thomas Gross

Academic history

Thomas Gross is a Visiting Professor of Pediatric Hematology/Oncology and Bone Marrow Transplantation at the University of Colorado Anschutz Medical Campus, Aurora, CO. He was previously Director of the Pediatric Blood and Marrow Transplant Program at Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, and the Division Chief and Gordon Teter Chair of Pediatric Cancer Research at Nationwide Children’s Hospital at Ohio State University, Columbus, OH. Previsously, Prof. Gross was also Deputy Director of Science for the Center for Global Health at the US National Cancer Institute (NCI), Bethesda, MD.

Prof. Gross received his medical degree and his PhD from the University of Nebraska Medical Center, Omaha, NE, with his PhD thesis being on the mechanisms of B-cell transformation by Epstein-Barr virus (EBV). He completed his residency in pediatrics at University of Nebraska Medical Center, Omaha, NE, and a fellowship in pediatric hematology/oncology at the University of Minnesota, Minneapolis, MN.

Speaking on lymphomas and cancers associated with immune deficiency

Prof. Gross is an international expert in pediatric lymphoma and blood and marrow transplantation. He has conducted research on EBV-associated post-transplant lymphoproliferative disease (PTLD), which can occur in patients after solid organ transplantation.

Prof. Gross has also recently been involved in several clinical trials relating to various lymphomas. Two such clinical trials include a Phase III trial investigating the safety and efficacy of multi-agent chemotherapy in pediatric patients with T-cell lymphoblastic lymphoma (T-LL) and a Phase III trial assessing rituximab in pediatric patients with mature B-cell non-Hodgkin’s lymphoma.